A recent review article by Azizieh et al. focused on the implementation of ex-vivo machine preservation and how it might change the perception of organ acceptability. By focusing on machine perfusion, they explored the effects of the different modalities on outcomes and look at how MP has contributed to modifying surgeon acceptance criteria and the role in decreasing discards.
They reviewed the most common reasons for organ discard, such as:
- Extended criteria donors (ECD), Standard criteria donors (SCD) and donors after circulatory death (DCD)
- Advanced age
- Steatosis, and
- Donor risk index
They then looked at the strategies for preserving these suboptimal organs, such as:
- Reducing ischemia reperfusion injury (IRI)
- Optimal preservation solutions, and
- Reducing ischemia time
Finally, they reviewed the different types of machine perfusion and their implications in graft utilization, including hypothermic machine perfusion, subnormothermic machine perfusion and normothermic machine perfusion. They noted that since machine perfusion is known to reduce IRI and allow the option to deliver targeted therapeutics, it is theoretically our best option to reduce the liver discard rate. Overall, they concluded that machine perfusion seems to be the ideal tool to improve grafts deemed unusable by combining old concepts with new technology and discovery.
Read the full article here: www.frontiersin.org/articles/10.3389/fmedt.2023.1079003/full
Check out the most recent posts
Novel Oxygenation Technique for Hypothermic Machine Perfusion of Liver Grafts: Validation in Porcine Donation after Cardiac Death (DCD) Liver Model
In a pre-clinical study using a porcine DCD model, Panayotova et al. sought to validate the novel technique of oxygen “pre-charge” for hypothermic machine perfusion (HMP) using the LifePort Liver Transporter. The study evaluated the effects of this preservation method...
David’s Transplant Journey
In this powerful video, we meet David, a liver recipient who shares his journey of needing a liver transplant. David speaks about the emotional and physical toll of waiting for a liver to become available, not knowing when or if he would receive that call. David takes...
Therapeutic Hypothermia or Hypothermic Machine Perfusion (HMP) which is best for Kidney Transplant Outcomes?
In 2023, Malinoski et al. published the results from a pragmatic, adaptive, prospective, randomized trial that was conducted between August 10, 2017, and May 21, 2020 involving six OPOs in the US. They sought to determine whether targeted mild hypothermia is as...
Business Wire—Organ Recovery Systems’ LifePort Liver Transporter Preserves First Livers for Transplant as Part of the PILOT Continued Access Study
We are proud to announce that the first livers have officially been transplanted using the LifePort®Liver Transporter as part of the PILOT™ Continued Access Study. The first livers preserved with the LLT under Continued Access were transplanted at University...